Investigating the use of biomarkers to predict pregnancy and long term complications in women who develop elevated blood pressure, gestational diabetes, fetal growth restriction or spontaneous preterm labour during pregnancy

Not Applicable

Recruiting

• Conditions: pre-eclampsia; Gestational Diabetes; Spontaneous preterm birth; Fetal growth restriction; Reproductive Health and Childbirth - Antenatal care; Reproductive Health and Childbirth - Fetal medicine and complications of pregnancy; Reproductive Health and Childbirth - Complications of newborn

• Registration Number: ACTRN12622001450707
• Lead Sponsor: ational Heart Foundation

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-11-14
• Last Update Posted: 21 November 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 600

Inclusion Criteria

1. Pregnant women at any gestation in pregnancy AND
2. Women who develop elevated blood pressure >130/80 OR
3. Women who have developed pregnancy complications (Gestational diabetes (GDM), Hypertensive disorder of pregnancy (HDP), Fetal growth restriction(FGR) and spontaneous preterm birth(sPTB))

Exclusion Criteria

1. Multiple pregnancy.
2. Pregnancy complicated by major fetal anomaly or genetic syndrome.
3. Maternal age less than 18 years,
4. Women incapable of giving valid consent (diminished understanding, non-English speaking
and interpreter unavailable).
5. Participation in a study where there is a pharmaceutical intervention that would likely modify the biomarkers under study.

Study & Design

• Study Type: Observational
• Study Design: Not specified